WAWANG ANWARUDIN. Cost-Effectiveness Analysis of Rifampicin and Bedaquiline Use for Tuberculosis Treatment: A Systematic Review. Journal of Health Economic and Policy Research (JHEPR), [S. l.], v. 4, n. 1, p. 95–103, 2026. DOI: 10.30595/jhepr.v4i1.442. Disponível em: https://ejournal.ump.ac.id/jhepr/article/view/442. Acesso em: 4 apr. 2026.